High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$143M
$143,448,355
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -13.9%
2026-03-04
$1,158,306Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -13.9%
|
2026-03-04 | $1,158,306Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-03-02 | $442,396 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bozic Carmen
• Officer • EVP and CMO
10b5-1 Sell
2026-02-27
$1,118,642Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and CMO
10b5-1 Sell
|
2026-02-27 | $1,118,642Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$19,738,855MEGAx13
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $19,738,855MEGAx13 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-26
$172,560
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-26 | $172,560 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-25
$108,456
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-25 | $108,456 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-25
$324,882
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-25 | $324,882 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-25
$459,601
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-25 | $459,601 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E.
• Officer • EVP, Chief Scientific Officer
10b5-1 Sell
2026-02-25
$301,537
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Scientific Officer
10b5-1 Sell
|
2026-02-25 | $301,537 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -11.1%
2026-02-25
$2,394,365Largex2
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -11.1%
|
2026-02-25 | $2,394,365Largex2 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-25
$897,802
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-25 | $897,802 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-25
$126,451
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-25 | $126,451 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$27,479,583MEGAx8
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $27,479,583MEGAx8 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-18
$302,208
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-18 | $302,208 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-18
$386,997
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-18 | $386,997 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-18
$589,258
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-18 | $589,258 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E.
• Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -12.2%
2026-02-18
$559,890
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -12.2%
|
2026-02-18 | $559,890 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-18
$174,314
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-18 | $174,314 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -15.7%
2026-02-17
$762,089
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -15.7%
|
2026-02-17 | $762,089 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-17
$994,093
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-17 | $994,093 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 SellΔOwn -12.7%
2026-02-17
$1,211,903Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 SellΔOwn -12.7%
|
2026-02-17 | $1,211,903Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E.
• Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -20.1%
2026-02-17
$1,192,814Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -20.1%
|
2026-02-17 | $1,192,814Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-17
$298,081
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-17 | $298,081 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bhatia Sangeeta N.
• Director
10b5-1 Sell
2026-02-13
$133,000
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Director
10b5-1 Sell
|
2026-02-13 | $133,000 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-13
$493,012
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-13 | $493,012 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-13
$749,985
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-13 | $749,985 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -12.0%
2026-02-11
$633,552
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -12.0%
|
2026-02-11 | $633,552 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-11
$806,213
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-11 | $806,213 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-11
$886,328
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-11 | $886,328 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E.
• Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -13.5%
2026-02-11
$930,529
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -13.5%
|
2026-02-11 | $930,529 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-11
$214,560
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-11 | $214,560 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-01-07
$2,137,455Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-01-07 | $2,137,455Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
10b5-1 SellΔOwn -20.2%
2026-01-06
$4,394,252Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
10b5-1 SellΔOwn -20.2%
|
2026-01-06 | $4,394,252Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2025-12-03
$155,803
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2025-12-03 | $155,803 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-12-03
$28,650,337MEGAx12
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $28,650,337MEGAx12 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2025-12-03
$2,024,955Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2025-12-03 | $2,024,955Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
10b5-1 SellΔOwn -13.5%
2025-12-03
$6,384,000Whalex2
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
10b5-1 SellΔOwn -13.5%
|
2025-12-03 | $6,384,000Whalex2 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 SellΔOwn -12.9%
2025-11-17
$1,086,450Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 SellΔOwn -12.9%
|
2025-11-17 | $1,086,450Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-11-14
$23,624,306MEGAx3
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-11-14 | $23,624,306MEGAx3 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-11-13
$8,668,014Whalex2
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-11-13 | $8,668,014Whalex2 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2025-10-02
$280,522
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2025-10-02 | $280,522 | S | Form 4 |